Zobrazeno 1 - 10
of 546
pro vyhledávání: ''
Autor:
Ana M. Bea, Jacinto Fernández-Pardo, Itziar Lamiquiz-Moneo, Estíbaliz Jarauta, Victoria Marco-Benedí, C. López-Ariño, Rocío Mateo-Gallego, Fernando Civeira, Ana Cenarro, Lia Ferraro
Publikováno v:
Atherosclerosis. 315:24-32
Background and aims Glycerol kinase deficiency (GKD) is a rare genetic disorder characterized by hyperglycerolemia and glyceroluria, which could be misdiagnosed as a moderate to severe hypertriglyceridemia (HTG). We aimed to describe four novel cases
Autor:
Daniel Bos, Maryam Kavousi, Dina Vojinovic, Najaf Amin, Sven J. van der Lee, Aad van der Lugt, Cornelia M. van Duijn, M. Arfan Ikram, Meike W. Vernooij, Ayse Demirkan
Publikováno v:
Atherosclerosis, 272, 60-65. Elsevier Ireland Ltd
Atherosclerosis
Vojinovic, D, van der Lee, S J, van Duijn, C M, Vernooij, M W, Kavousi, M, Amin, N, Demirkan, A, Ikram, M A, van der Lugt, A & Bos, D 2018, ' Metabolic profiling of intra-and extracranial carotid artery atherosclerosis ', Atherosclerosis, vol. 272, pp. 60-65 . https://doi.org/10.1016/j.atherosclerosis.2018.03.015
Atherosclerosis
Vojinovic, D, van der Lee, S J, van Duijn, C M, Vernooij, M W, Kavousi, M, Amin, N, Demirkan, A, Ikram, M A, van der Lugt, A & Bos, D 2018, ' Metabolic profiling of intra-and extracranial carotid artery atherosclerosis ', Atherosclerosis, vol. 272, pp. 60-65 . https://doi.org/10.1016/j.atherosclerosis.2018.03.015
Background and aims Increasing evidence shows that intracranial carotid artery atherosclerosis may develop under the influence of a differential metabolic risk factor profile than atherosclerosis in the extracranial part of the carotid artery. To fur
Autor:
Masaki Sumi, Akira Fujiyoshi, Takashi Hisamatsu, Yasuharu Tabara, Katsuyuki Miura, Naoyuki Takashima, Maryam Zaid, Katsuhiko Kohara, Tetsuro Miki, Hirotsugu Ueshima
Publikováno v:
Atherosclerosis. 254:242-248
While alcohol consumption is known to increase plasma high-density lipoprotein (HDL) cholesterol levels, its relationship with low-density lipoprotein (LDL) cholesterol levels is unclear. Aldehyde dehydrogenase 2 (ALDH2) is a rate-controlling enzyme
Autor:
Alejandro Gugliucci, Ayca Erkin-Cakmak, Robert H. Lustig, Jean-Marc Schwarz, Kathleen Mulligan, Russell Caccavello, Susan M. Noworolski, Viva W. Tai, Michael J. Wen
Publikováno v:
Gugliucci, A; Lustig, RH; Caccavello, R; Erkin-Cakmak, A; Noworolski, SM; Tai, VW; et al.(2016). Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome. ATHEROSCLEROSIS, 253, 171-177. doi: 10.1016/j.atherosclerosis.2016.06.048. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/9kh4z08n
Background and aimsDietary fructose may play a role in the pathogenesis of metabolic syndrome (MetS). In a recently published study of obese children with MetS, we showed that isocaloric fructose restriction reduced fasting triglyceride (TG) and LDL-
Publikováno v:
Atherosclerosis. 249:59-64
Hyperhomocysteinemia is an independent risk factor for cardiovascular disease, but the mechanism for this risk remains unclear. While reducing serum total homocysteine (tHcy) has been shown to decrease strokes, there is no evidence for an effect on m
Autor:
Rosa Gilabert, Zoe Herreras, Aleix Sala-Vila, Montserrat Cofán, Emilio Ros, Marta Catalan, Emilio Ortega, Antonio Pérez, Antonio J. Amor, Montserrat Pinyol
Publikováno v:
ATHEROSCLEROSIS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background and Aims: Atherogenic dyslipidemia is common in type 2 diabetes (T2DM) and predicts cardiovascular disease, but information on the association of its components with atherosclerosis is scarce. We aimed to assess differences in the lipoprot
Autor:
Zhen-Yu Chen, Junkuan Wang, Yu Huang, Lin Lei, Lei Guan, Sun Wa Man, Yuwei Liu, Xiaobo Wang, Youyou Zhao, Ka Ying Ma, Lijun Wang
Publikováno v:
Atherosclerosis. 242:77-86
Objective Cholesterol analogs have been used to treat hypercholesterolemia. The present study was to examine the effect of dihydrocholesterol (DC) on plasma total cholesterol (TC) compared with that of β-sitosterol (SI) in hamsters fed a high choles
Autor:
Menno Hoekstra, Hiroyuki Ebinuma, Ranitha Vongpromek, Leonie C. van Vark-van der Zee, Willem A. Dik, Hideaki Bujo, Arend F.L. Schinkel, Wolfgang J. Schneider, Adrie J.M. Verhoeven, Monique T. Mulder, Meizi Jiang, Eric J.G. Sijbrands, Suzanne J.A. Korporaal
Publikováno v:
Atherosclerosis, 243(2), 429-437. Elsevier Ireland Ltd
Atherosclerosis, 243(2), 429. Elsevier
Atherosclerosis, 243(2), 429. Elsevier
Objective: Familial Hypercholesterolemia (FH) is associated with an increased risk of cardiovascular disease (CVD). However, whether an individual heterozygous FH patient will develop CVD depends on other genetic-and environmental risk factors as wel
Autor:
Chuanhui Dong, Ronald B. Goldberg, Ying Kuen Cheung, Hannah Gardener, Eduard Tiozzo, Milita Crisby, David Della-Morte, Ralph L. Sacco, Clinton B. Wright, Barry I. Hudson, Mitchell S.V. Elkind, Tatjana Rundek
Publikováno v:
Atherosclerosis. 237:163-168
The objective of this cross-sectional analysis was to investigate the relation between two major high-density lipoprotein cholesterol (HDL-C) subfractions (HDL2-C and HDL3-C) and carotid plaque in a population based cohort.We evaluated 988 stroke-fre
Autor:
José Manuel Fort, Juan Antonio Baena-Fustegueras, Roser Ferrer, Montserrat Pérez-Cuellar, José Luis Sánchez-Quesada, Eva Pardina, Albert Lecube, Joana Rossell, Francisco Blanco-Vaca, Julia Peinado-Onsurbe, Josep Julve
Publikováno v:
ATHEROSCLEROSIS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Objective: The purpose of this study was to evaluate the effect of weight loss induced in morbidly obese subjects by Roux-en-Y gastric bypass bariatric surgery on the atherogenic features of their plasma lipoproteins. Methods: Twenty-one morbidly obe